Hospitalization costs of TAVI in one Belgian university hospital

Gestel, Raf Van; Graeve, Diana De; Vrints, Christiaan; Rodrigus, Inez; Bosmans, Johan

doi:10.1080/ac.68.3.2983420

Cited by 8 publications

(3 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The transcatheter heart valve (THV) prosthesis itself has a substantial acquisition cost that is 5–6 times that of a surgical prosthesis. The bulk of the previous work on TAVI17 18 20 33 and SAVR34 related costs has focused on the importance of complications and the incremental costs associated with them.…”

Section: Discussionmentioning

confidence: 99%

Drivers of healthcare costs associated with the episode of care for surgical aortic valve replacement versus transcatheter aortic valve implantation

Wijeysundera

Braga

et al. 2016

Open Heart

View full text Add to dashboard Cite

ObjectiveTranscatheter aortic valve implantation (TAVI) is generally more expensive than surgical aortic valve replacement (SAVR) due to the high cost of the device. Our objective was to understand the patient and procedural drivers of cumulative healthcare costs during the index hospitalisation for these procedures.DesignAll patients undergoing TAVI, isolated SAVR or combined SAVR+coronary artery bypass grafting (CABG) at 7 hospitals in Ontario, Canada were identified during the fiscal year 2012–2013. Data were obtained from a prospective registry. Cumulative healthcare costs during the episode of care were determined using microcosting. To identify drivers of healthcare costs, multivariable hierarchical generalised linear models with a logarithmic link and γ distribution were developed for TAVI, SAVR and SAVR+CABG separately.ResultsOur cohort consisted of 1310 patients with aortic stenosis, of whom 585 underwent isolated SAVR, 518 had SAVR+CABG and 207 underwent TAVI. The median costs for the index hospitalisation for isolated SAVR were $21 811 (IQR $18 148–$30 498), while those for SAVR+CABG were $27 256 (IQR $21 741–$39 000), compared with $42 742 (IQR $37 295–$56 196) for TAVI. For SAVR, the major patient-level drivers of costs were age >75 years, renal dysfunction and active endocarditis. For TAVI, chronic lung disease was a major patient-level driver. Procedural drivers of cost for TAVI included a non-transfemoral approach. A prolonged intensive care unit stay was associated with increased costs for all procedures.ConclusionsWe found wide variation in healthcare costs for SAVR compared with TAVI, with different patient-level drivers as well as potentially modifiable procedural factors. These highlight areas of further study to optimise healthcare delivery.

show abstract

Section: Discussionmentioning

confidence: 99%

Drivers of healthcare costs associated with the episode of care for surgical aortic valve replacement versus transcatheter aortic valve implantation

Wijeysundera

Braga

et al. 2016

Open Heart

View full text Add to dashboard Cite

show abstract

“…A study from the University of Antwerp, Belgium for instance reported average costs of hospitalization of €38,739 [13]. In another study based on the FRANCE registry [27] the estimated average cost of hospitalization was €35,164 [15].…”

Section: Ta Instead Of Tf-tavimentioning

confidence: 98%

“…A Belgian group found costs to be highly insensitive to pre-existing patient characteristics with an average estimate of €38,739 [13]. Similarly Italian and French analyses of TAVR costs reported mean values of €35,841 and €35,164 [14,15].…”

Section: Introductionmentioning

confidence: 97%